<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03910088</url>
  </required_header>
  <id_info>
    <org_study_id>CairoU11112017</org_study_id>
    <nct_id>NCT03910088</nct_id>
  </id_info>
  <brief_title>Pregabalin Versus Hydrocortisone for Postdural Puncture Headache After Spinal for Cesarean</brief_title>
  <acronym>PDPH</acronym>
  <official_title>Oral Pregabalin Versus Intravenous Hydrocortisone in Treatment of Postdural Puncture Headache After Spinal Anesthesia for Elective Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postdural puncture headache (PDPH) is a common complication after spinal anesthesia. The role
      of pregabalin and hydrocortisone in the treatment of PDPH is unclear. The aim of this work is
      to assess and compare the efficacy of both drugs in severe cases of PDPH after spinal
      anesthesia for elective cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be done on 30 patient with PDPH with VAS score â‰¥ 5 after spinal anesthesia for
      elective cesarean section. Patients will be divided into three groups: Control group (group
      C):will receive conventional treatment in the form of good oral hydration, 500 mg of
      acetaminophen plus 65 mg of caffeine oral tablets thrice daily, 3 cups of coffee daily, 50 mg
      of diclofenac potassium oral tablets twice daily and recumbent positioning for 48 hours.
      Pregabalin group (group P): will receive the conventional treatment plus 100 mg of pregabalin
      oral tablet every 8 hours for 48 hours. Hydrocortisone group (group H): will receive the
      conventional treatment plus 100 mg of hydrocortisone IV every 8 hours for 48 hours. The three
      groups will be compared regarding the headache intensity using a visual analog scale.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 20, 2019</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of pain using Visual Analogue Scale</measure>
    <time_frame>the first 48 hours following treatment</time_frame>
    <description>Headache intensity after 1 minute in upright position using the Visual Analogue Scale for pain assessment ranging from 0 to 10, with zero means no pain and 10 is the worst pain after 48 hours of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the amount of rescue drug</measure>
    <time_frame>The first 48 hours following treatment</time_frame>
    <description>Total dose of nalbuphine given in each group..</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of side effects of the studied drug</measure>
    <time_frame>the first 48 hours following treatment</time_frame>
    <description>incidence of Somnolence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of side effect of the studied drug</measure>
    <time_frame>the first 48 hours following treatment</time_frame>
    <description>incidence of dizziness</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Post-Dural Puncture Headache</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>received conventional treatment in the form of good oral hydration, 500 mg of acetaminophen plus 65 mg of caffeine oral tablets thrice daily, 3 cups of coffee daily, 50 mg of diclofenac potassium oral tablets twice daily and recumbent positioning for 48 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received the conventional treatment plus 100 mg of pregabalin oral tablet every 8 hours for 48 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrocortisone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received the conventional treatment plus 100 mg of hydrocortisone IV every 8 hours for 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin 100Mg Oral Cap</intervention_name>
    <description>giving a drug to relieve post-dural puncture headache</description>
    <arm_group_label>Pregabalin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>Giving drug to relieve post-dural puncture headache</description>
    <arm_group_label>Hydrocortisone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>giving a drug to relieve post-dural puncture headache</description>
    <arm_group_label>Hydrocortisone</arm_group_label>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>Paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oral fluids</intervention_name>
    <description>giving oral fluids to maintain good hydration</description>
    <arm_group_label>Hydrocortisone</arm_group_label>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>good hydration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>giving a drug to relieve post-dural puncture headache</description>
    <arm_group_label>Hydrocortisone</arm_group_label>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>giving a drug to relieve post-dural puncture headache</description>
    <arm_group_label>Hydrocortisone</arm_group_label>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who underwent elective cesarean section under spinal anesthesia.

          -  Patients aged 18 to 40 years old.

          -  Patients classified as ASA I or II.

        Exclusion Criteria:

          -  Patients with known sensitivity to any of the used drugs.

          -  Patients classified as ASA III or more.

          -  Preeclampsia.

          -  Patients with a history of chronic headache or migraine Patients receiving pregabalin
             for chronic pain.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>The study group is the pregnant females undergoing cesarean section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>Zamalek</state>
        <zip>11586</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>April 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2019</study_first_posted>
  <last_update_submitted>November 7, 2019</last_update_submitted>
  <last_update_submitted_qc>November 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nesrine El-Refai</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>spinal</keyword>
  <keyword>cesarean</keyword>
  <keyword>pregabalin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

